☆ 4.7 Article

O-012The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer

ANNALS OF ONCOLOGY (2019)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 30, Issue Supplement_4, Pages -

Publisher

Oxford University Press (OUP)
DOI: 10.1093/annonc/mdz154.011

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.